UNLOCKING THE POWER OF MAGNESIUM: A SYSTEMIC REVIEW AND META ANALYSIS REGARDING ITS ROLE IN METABOLIC DISORDER [DIABETES]

Magnesium is an important micronutrient that regulates glucose homeostasis, insulin signaling, and energy metabolism. New research reveals that magnesium insufficiency is widespread in people with metabolic disorders, notably type 2 diabetes mellitus (T2DM), and may contribute to illness development and progression. The purpose of this systematic review and meta-analysis was to assess the relationship between magnesium consumption or supplementation and diabetes-related metabolic outcomes. Electronic databases such as PubMed, Scopus, and Web of Science were rigorously searched for observational studies and randomized controlled trials (RCTs) that examined dietary magnesium intake, serum magnesium levels, or magnesium supplementation in connection to diabetes risk and glycemic control. Incidence of type 2 diabetes, fasting plasma glucose, insulin resistance indicators, HbA1c, lipid profile, and blood pressure were among the outcomes of interest. The risk of acquiring type 2 diabetes is inversely correlated with dietary magnesium consumption, according to data from prospective cohort studies; dose-response analyses show that increased intake significantly reduces risk. Although effects on HbA1c were modest and varied, meta-analyses of RCTs showed that magnesium supplementation significantly improved insulin sensitivity and fasting blood glucose, especially in people with magnesium deficiency or poor glycemic control. Benefits also included improvements in blood pressure and cholesterol profiles, which may indicate more extensive cardio metabolic protection. Enhanced insulin receptor function, better glucose transport, decreased inflammation, and oxidative stress control are some of the suggested causes. Magnesium has been shown to have a positive function in the prevention and treatment of metabolic diseases, despite variations in study design, dosage, and duration. Making sure you consume enough magnesium through your diet and using specific supplements could be a low-risk, safe supplemental approach to diabetes treatment. More extensive, long-term studies are necessary to determine the best dosage and clinical recommendations.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-16
DOI
https://doi.org/10.5281/zenodo.18657663
Primary Topic
Magnesium in Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UNLOCKING THE POWER OF MAGNESIUM: A SYSTEMIC REVIEW AND META ANALYSIS REGARDING ITS ROLE IN METABOLIC DISORDER [DIABETES]

Bhargav Saganaboina1, Revathi Boyina*2, J. Madhulatha3, P. Jhanavi4, P. Sameena5
Zenodo (CERN European Organization for Nuclear Research)
Magnesium in Health and Disease
article

UNLOCKING THE POWER OF MAGNESIUM: A SYSTEMIC REVIEW AND META ANALYSIS REGARDING ITS ROLE IN METABOLIC DISORDER [DIABETES]

Bhargav Saganaboina1, Revathi Boyina*2, J. Madhulatha3, P. Jhanavi4, P. Sameena5
article en

Abstract

Magnesium is an important micronutrient that regulates glucose homeostasis, insulin signaling, and energy metabolism. New research reveals that magnesium insufficiency is widespread in people with metabolic disorders, notably type 2 diabetes mellitus (T2DM), and may contribute to illness development and progression. The purpose of this systematic review and meta-analysis was to assess the relationship between magnesium consumption or supplementation and diabetes-related metabolic outcomes. Electronic databases such as PubMed, Scopus, and Web of Science were rigorously searched for observational studies and randomized controlled trials (RCTs) that examined dietary magnesium intake, serum magnesium levels, or magnesium supplementation in connection to diabetes risk and glycemic control. Incidence of type 2 diabetes, fasting plasma glucose, insulin resistance indicators, HbA1c, lipid profile, and blood pressure were among the outcomes of interest. The risk of acquiring type 2 diabetes is inversely correlated with dietary magnesium consumption, according to data from prospective cohort studies; dose-response analyses show that increased intake significantly reduces risk. Although effects on HbA1c were modest and varied, meta-analyses of RCTs showed that magnesium supplementation significantly improved insulin sensitivity and fasting blood glucose, especially in people with magnesium deficiency or poor glycemic control. Benefits also included improvements in blood pressure and cholesterol profiles, which may indicate more extensive cardio metabolic protection. Enhanced insulin receptor function, better glucose transport, decreased inflammation, and oxidative stress control are some of the suggested causes. Magnesium has been shown to have a positive function in the prevention and treatment of metabolic diseases, despite variations in study design, dosage, and duration. Making sure you consume enough magnesium through your diet and using specific supplements could be a low-risk, safe supplemental approach to diabetes treatment. More extensive, long-term studies are necessary to determine the best dosage and clinical recommendations.

Zenodo (CERN European Organization for Nuclear Research)
Zero hunger
Openalex Percentile: Top 53%
Magnesium in Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.